OTTAWA — Canadian women experience a significant decline in health and quality of life between the ages of 40 and 50, compared to men during the same period of life, suggests a Statistics Canada study.
The study, released Wednesday, suggests women in their 40s experience more health problems — for example, illness linked to emotional stress — that lead to a poorer quality of life than their male counterparts during that particular Read the rest of this entry »

(Adds analysts’ comments, updates stock movement)
Dec 9 (Reuters) – Targanta Therapeutics Corp said U.S. health regulators declined the approval of its antibiotic and raised questions about the safety of the drug, triggering a 63 percent drop in its shares.
The U.S. Food and Drug Administration asked the company to perform an additional clinical study to show efficacy and safety of the drug, oritavancin, for treating complicated skin and skin Read the rest of this entry »

OTTAWA — Canadian women experience a significant decline in health and quality of life between the ages of 40 and 50, compared to men during the same period of life, suggests a Statistics Canada study.
The study, released Wednesday, suggests women in their 40s experience more health problems — for example, illness linked to emotional stress — that lead to a poorer quality of life than their male counterparts during that particular Read the rest of this entry »

Declining incidence and death rates for some of the nation’s most common cancers mean physicians can take a deep breath, pat themselves on the back and keep up the good work.
It looks like increasing screening rates and encouraging patients to toss out the cigarettes are effective strategies, but more patients should be following through on both, according to the “Annual Report to the Nation on the Status of Cancer, 1975-2005.”
The report, Read the rest of this entry »

Updated from 1:07 p.m. EST
said Tuesday that the U.S. drug regulators decided not to approve the company’s injectable antiobiotic oritavancin until an additional clinical study is performed.
The U.S. Food and Drug Administration’s rejection of oritavancin isn’t a complete surprise. In late November, an FDA advisory panel voted 10-8 against recommending approval. That decision sent Targanta shares sliding more than 80%.
Targanta shares closed Read the rest of this entry »

(RTTNews) - 
Monday, Rochester Medical Corp. (ROCM:
), a manufacturer of urinary continence and urine drainage care products, reported a sharp decline in its first quarter earnings, hurt by higher costs.
The Stewartville, Minnesota-based company reported a net income of $54 thousand, down from $272 thousand in the year-ago quarter. On per-share basis, the company reported a breakeven earnings compared to $0.02 Read the rest of this entry »

(RTTNews) - 
Medical House Plc (MLH.L:
) announced its financial results for the six months ended 30 June 2008, reporting a net loss of ВЈ101 thousand or 0.17 pence per share, in comparison with a net loss of ВЈ340 thousand or 0.57 pence per share in the same period last year.
From continuing operations, the company’s profit declined to ВЈ216 thousand or 0.36 pence per share, from ВЈ252 thousand or 0.42 Read the rest of this entry »

The U.S. Food and Drug Administration has declined to immediately approve
Eli
Lilly & Co.’s
(LLY) application to market a long-acting formulation of its
antipsychotic Zyprexa.
said Wednesday the drug maker received a
so-called complete response letter from the FDA. Such letters typically mean the
FDA isn’t yet ready to approve a drug candidate. Lechleiter disclosed receipt of
the letter at a Goldman Sachs investor conference in
, which was
broadcast Read the rest of this entry »

(RTTNews) - 
Span-America Medical Systems Inc. (SPAN:
) reported that its first quarter net income declined 15% to $0.9 million from $1.04 million in the year-ago quarter. On per share basis, net income decreased 14% to $0.32 from $0.37 in the same quarter last year.
The company’s quarterly net sales declined 2% to $13.4 million, from $13.66 million in the same quarter previous year. Operating income for Read the rest of this entry »

Costa’s U.N. agency issues its annual report after gathering information throughout the year via satellite photographs followed up by surveillance on the ground.
This year’s turnaround was also attributed to events unrelated to the eradication effort, including a drought and global food shortage that drove up the price of wheat, making it almost as profitable to farm as opium.
“You produce wheat and that gets you a better income and you’re not Read the rest of this entry »